Table 2 Comparison between MS patients and control individuals of the Taq-I (T > C) and Bsm-I (G > A) polymorphisms of the VDR gene
From: Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece
Enzyme analysis n | Patients (69) | Controls (81) | p |
|---|---|---|---|
Taq-I polymorphism | |||
Genotype | |||
TT | 30 (43.5%) | 33 (44.8%) | 0.91 |
CT | 30 (43.5%) | 36 (44.4%) | 0.94 |
CC | 9 (13%) | 12 (14.8%) | 0.9 |
Allele | |||
T | 65.2% | 63% | 0.78 |
C | 34.8% | 37% | 0.80 |
Bsm-I polymorphism | |||
Genotype | |||
GG | 28 (40%) | 26 (32%) | 0.54 |
GA | 41 (60%) | 55 (68%) | 0.42 |
AA | 0 | 0 | |
Allele | |||
G | 70% | 66% | 0.60 |
A | 30% | 34% | 0.6 |